Richard D Finkelman
Overview
Explore the profile of Richard D Finkelman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan A, Abbott L, Ahmed I, Ayodele O, Gagnon C, Finkelman R, et al.
JBMR Plus
. 2024 May;
8(3):ziad010.
PMID: 38741607
Clinical Trial Identifier: NCT03364738.
2.
Rubin M, Cusano N, Yin S, Tokareva E, Ayodele O, Finkelman R
Endocr Pract
. 2023 Dec;
30(3):200-208.
PMID: 38086524
Objective: Recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) is efficacious in patients with hypoparathyroidism but additional data supporting its prolonged use are needed. We evaluated whether efficacy, safety, and tolerability are...
3.
Ing S, Finkelman R, He P, Khan A, Mannstadt M, Rejnmark L, et al.
JBMR Plus
. 2023 Jul;
7(7):e10758.
PMID: 37457880
Recombinant human parathyroid hormone (1-84), rhPTH(1-84), is an approved adjunctive treatment to oral calcium and active vitamin D for adult patients with hypoparathyroidism; however, there is limited information on the...
4.
Song I, Finkelman R, Lan L
Drugs R D
. 2020 Oct;
20(4):359-367.
PMID: 33057953
Background And Objectives: Currently, there are no US FDA-approved therapies for eosinophilic esophagitis (EoE). Budesonide oral suspension (BOS; SHP621, TAK-721) is a viscous, muco-adherent, oral formulation of budesonide that is...
5.
6.
Finkelman R, Russell J, Scarborough N, Chesmel K, Schwartz Z, Wlodarski K, et al.
J Periodontol
. 2018 Mar;
68(8):804-807.
PMID: 29539835
No abstract available.
7.
8.
Chen N, Cui D, Wang Q, Wen Z, Finkelman R, Welty D
Xenobiotica
. 2017 Jul;
48(6):637-646.
PMID: 28730856
1. Budesonide is a glucocorticoid used in the treatment of several respiratory and gastrointestinal inflammatory diseases. Glucocorticoids have been demonstrated to induce cytochrome P450 (CYP) 3A and the efflux transporter...
9.
George J, Kakkar R, Marshall J, Scott M, Finkelman R, Ho T, et al.
J Clin Endocrinol Metab
. 2016 Jul;
101(11):4313-4321.
PMID: 27459523
Context: Polycystic ovary syndrome (PCOS), the most common endocrinopathy in women, is characterized by high secretion levels of LH and T. Currently, there is no treatment licensed specifically for PCOS....
10.
Effect of CYP2C19 polymorphism on the pharmacokinetics of rosuvastatin in healthy Taiwanese subjects
Finkelman R, Wang T, Wang Y, Azumaya C, Birmingham B, Wissmar J, et al.
Clin Pharmacol Drug Dev
. 2016 Apr;
4(1):33-40.
PMID: 27128002
CYP2C19 contributes to N-desmethyl rosuvastatin formation in "in vitro" models. Approximately 80% of Taiwanese are CYP2C19 extensive metabolizers (EMs, CYP2C19*1/*1, *1/*2, or *1/*3). We studied the potential effect of CYP2C19...